Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Does the World Continue to Struggle with Preventable Patient Harm?

Patient safety is something every healthcare organization wants to improve upon, especially with the shift to value-based care. However, most are missing the mark with preventable patient harm and truly being patient-centric. Discussing the topic today, B2B Today host Daniel Litwin spoke with Dr. Donna Prosser, Chief Clinical Officer of the Patient Safety Movement Foundation, a nonprofit…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

Patient safety is something every healthcare organization wants to improve upon, especially with the shift to value-based care. However, most are missing the mark with preventable patient harm and truly being patient-centric. Discussing the topic today, B2B Today host Daniel Litwin spoke with Dr. Donna Prosser, Chief Clinical Officer of the Patient Safety Movement Foundation, a nonprofit that’s goal to reach zero preventable patient harm and deaths. The company will host the #UniteForSafeCare event on World Patient Day on September 17.

“There had been success in improving patient safety, but that fell apart during COVID because there was a hyper-focus. It comes down to the lack of a high-reliability foundation,” Dr. Prosser noted.

“Hospitals are businesses and concerned about public image and marketability. That sustains a culture of silence where no one talks about the issues.” – Dr. Donna Prosser

Dr. Prosser argued that while organizations say they are patient-focused, the processes and structure of healthcare is clinician-focused. That could be why some clinicians seem to make numerous errors undetected, as seen in the upcoming TV show Dr. Death, which centers on a real neurosurgeon’s medical incompetence.

“This is at the far end of the spectrum, but other situations happen regularly because of the way the system is set up. Transparency, openness, and trust aren’t there. People saw this behavior and didn’t feel comfortable voicing it or hit a wall if they did,” Dr. Prosser explained.

This “culture of silence” is what perpetuates preventable patient harm. That’s reflected in research. One survey found that 6% of patients were affected, while another from the World Health Organization (WHO) found that four in 10 patients suffered some harm.

So, what’s the answer to address preventable harm? Dr. Prosser said, “No one can do it alone. All stakeholders have to be at the table. We have to band together, shine a light on it, address it, and create those highly reliable systems. It will require culture change.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

AI Shouldn't Replace Physicists - It Should Give Them Time Back

AI Shouldn't Replace Physicists - It Should Give Them Time Back

The article discusses the role of AI in the healthcare industry, emphasizing that AI should enhance the efficiency of physicists rather than replace them. TheraPanacea, founded by mathematician Nico Asperagus, focuses on developing AI platforms to improve efficiency and standardization in healthcare. The aim is for AI to handle routine tasks, allowing professionals more time for complex problem-solving.

  • 01AI should be used to enhance the efficiency of physicists rather than replace them.
  • 02TheraPanacea develops AI platforms for improving efficiency and standardization in healthcare.
  • 03AI platforms aim to manage routine tasks, allowing professionals more time for complex analysis.

Aug 7, 2026

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512